GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
REST
|
ENSG00000084093.11 | RE1 silencing transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
REST | hg19_v2_chr4_+_57774042_57774114 | -0.42 | 8.4e-11 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr20_+_44657845 | 78.67 |
ENST00000243964.3
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5 |
chr4_+_158141806 | 78.24 |
ENST00000393815.2
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
chr4_+_158141843 | 76.64 |
ENST00000509417.1
ENST00000296526.7 |
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
chr4_+_158141899 | 73.98 |
ENST00000264426.9
ENST00000506284.1 |
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
chr14_+_93389425 | 72.93 |
ENST00000216492.5
ENST00000334654.4 |
CHGA
|
chromogranin A (parathyroid secretory protein 1) |
chr12_+_175930 | 71.12 |
ENST00000538872.1
ENST00000326261.4 |
IQSEC3
|
IQ motif and Sec7 domain 3 |
chrX_-_47479246 | 68.50 |
ENST00000295987.7
ENST00000340666.4 |
SYN1
|
synapsin I |
chr1_+_65775204 | 66.84 |
ENST00000371069.4
|
DNAJC6
|
DnaJ (Hsp40) homolog, subfamily C, member 6 |
chr12_+_113229452 | 62.82 |
ENST00000389385.4
|
RPH3A
|
rabphilin 3A homolog (mouse) |
chr12_+_113229737 | 61.90 |
ENST00000551052.1
ENST00000415485.3 |
RPH3A
|
rabphilin 3A homolog (mouse) |
chr1_+_33352036 | 61.88 |
ENST00000373467.3
|
HPCA
|
hippocalcin |
chr20_+_5892037 | 61.81 |
ENST00000378961.4
|
CHGB
|
chromogranin B (secretogranin 1) |
chr12_+_113229543 | 60.27 |
ENST00000447659.2
|
RPH3A
|
rabphilin 3A homolog (mouse) |
chr17_+_42385927 | 57.97 |
ENST00000426726.3
ENST00000590941.1 ENST00000225441.7 |
RUNDC3A
|
RUN domain containing 3A |
chr15_+_75287861 | 56.48 |
ENST00000425597.3
ENST00000562327.1 ENST00000568018.1 ENST00000562212.1 ENST00000567920.1 ENST00000566872.1 ENST00000361900.6 ENST00000545456.1 |
SCAMP5
|
secretory carrier membrane protein 5 |
chr15_-_83378638 | 52.61 |
ENST00000261722.3
|
AP3B2
|
adaptor-related protein complex 3, beta 2 subunit |
chrX_-_49056635 | 51.37 |
ENST00000472598.1
ENST00000538567.1 ENST00000479808.1 ENST00000263233.4 |
SYP
|
synaptophysin |
chr17_+_30813576 | 50.16 |
ENST00000313401.3
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
chr1_-_241520385 | 45.32 |
ENST00000366564.1
|
RGS7
|
regulator of G-protein signaling 7 |
chr11_-_66115032 | 45.02 |
ENST00000311181.4
|
B3GNT1
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 |
chr15_-_83378526 | 44.85 |
ENST00000535348.1
ENST00000535359.1 |
AP3B2
|
adaptor-related protein complex 3, beta 2 subunit |
chr2_-_51259292 | 39.31 |
ENST00000401669.2
|
NRXN1
|
neurexin 1 |
chr8_-_57358432 | 37.92 |
ENST00000517415.1
ENST00000314922.3 |
PENK
|
proenkephalin |
chr2_-_51259229 | 36.99 |
ENST00000405472.3
|
NRXN1
|
neurexin 1 |
chr10_+_26505594 | 36.82 |
ENST00000259271.3
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) |
chr10_-_102790852 | 35.89 |
ENST00000470414.1
ENST00000370215.3 |
PDZD7
|
PDZ domain containing 7 |
chr15_-_83378611 | 34.37 |
ENST00000542200.1
|
AP3B2
|
adaptor-related protein complex 3, beta 2 subunit |
chr2_-_51259641 | 33.11 |
ENST00000406316.2
ENST00000405581.1 |
NRXN1
|
neurexin 1 |
chr10_-_50970322 | 33.09 |
ENST00000374103.4
|
OGDHL
|
oxoglutarate dehydrogenase-like |
chr16_+_5008290 | 31.42 |
ENST00000251170.7
|
SEC14L5
|
SEC14-like 5 (S. cerevisiae) |
chr2_-_51259528 | 31.30 |
ENST00000404971.1
|
NRXN1
|
neurexin 1 |
chr10_-_50970382 | 28.87 |
ENST00000419399.1
ENST00000432695.1 |
OGDHL
|
oxoglutarate dehydrogenase-like |
chr9_+_140033862 | 27.14 |
ENST00000350902.5
ENST00000371550.4 ENST00000371546.4 ENST00000371555.4 ENST00000371553.3 ENST00000371559.4 ENST00000371560.3 |
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
chr3_-_48700310 | 25.46 |
ENST00000164024.4
ENST00000544264.1 |
CELSR3
|
cadherin, EGF LAG seven-pass G-type receptor 3 |
chrX_+_153237740 | 25.05 |
ENST00000369982.4
|
TMEM187
|
transmembrane protein 187 |
chr3_+_62304712 | 25.00 |
ENST00000494481.1
|
C3orf14
|
chromosome 3 open reading frame 14 |
chr19_-_55691472 | 24.70 |
ENST00000537500.1
|
SYT5
|
synaptotagmin V |
chr19_-_55691614 | 23.87 |
ENST00000592470.1
ENST00000354308.3 |
SYT5
|
synaptotagmin V |
chr11_+_45907177 | 23.26 |
ENST00000241014.2
|
MAPK8IP1
|
mitogen-activated protein kinase 8 interacting protein 1 |
chr9_-_139096955 | 21.57 |
ENST00000371748.5
|
LHX3
|
LIM homeobox 3 |
chr2_-_47798044 | 20.53 |
ENST00000327876.4
|
KCNK12
|
potassium channel, subfamily K, member 12 |
chrX_-_153141302 | 20.21 |
ENST00000361699.4
ENST00000543994.1 ENST00000370057.3 ENST00000538883.1 ENST00000361981.3 |
L1CAM
|
L1 cell adhesion molecule |
chr3_+_62304648 | 20.15 |
ENST00000462069.1
ENST00000232519.5 ENST00000465142.1 |
C3orf14
|
chromosome 3 open reading frame 14 |
chr1_-_151689259 | 19.78 |
ENST00000420342.1
ENST00000290583.4 |
CELF3
|
CUGBP, Elav-like family member 3 |
chr16_+_3019246 | 19.33 |
ENST00000318782.8
ENST00000293978.8 |
PAQR4
|
progestin and adipoQ receptor family member IV |
chr19_-_3971050 | 19.31 |
ENST00000545797.2
ENST00000596311.1 |
DAPK3
|
death-associated protein kinase 3 |
chr1_+_154540246 | 17.33 |
ENST00000368476.3
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal) |
chrX_-_153237258 | 16.39 |
ENST00000310441.7
|
HCFC1
|
host cell factor C1 (VP16-accessory protein) |
chr16_+_335680 | 16.26 |
ENST00000435833.1
|
PDIA2
|
protein disulfide isomerase family A, member 2 |
chr8_-_91095099 | 15.49 |
ENST00000265431.3
|
CALB1
|
calbindin 1, 28kDa |
chr2_+_46524537 | 15.43 |
ENST00000263734.3
|
EPAS1
|
endothelial PAS domain protein 1 |
chr10_+_26505179 | 15.42 |
ENST00000376261.3
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) |
chr6_+_154360616 | 14.12 |
ENST00000229768.5
ENST00000419506.2 ENST00000524163.1 ENST00000414028.2 ENST00000435918.2 ENST00000337049.4 |
OPRM1
|
opioid receptor, mu 1 |
chr17_-_3301704 | 13.69 |
ENST00000322608.2
|
OR1E1
|
olfactory receptor, family 1, subfamily E, member 1 |
chr2_-_30143525 | 13.65 |
ENST00000431873.1
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase |
chr15_-_27018884 | 13.47 |
ENST00000299267.4
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
chr6_+_25652432 | 13.30 |
ENST00000377961.2
|
SCGN
|
secretagogin, EF-hand calcium binding protein |
chr6_+_110299501 | 12.10 |
ENST00000414000.2
|
GPR6
|
G protein-coupled receptor 6 |
chr10_-_79398250 | 11.84 |
ENST00000286627.5
|
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr9_-_123812542 | 11.20 |
ENST00000223642.1
|
C5
|
complement component 5 |
chr7_+_154862028 | 11.11 |
ENST00000287907.2
|
HTR5A
|
5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled |
chr10_-_44880491 | 10.94 |
ENST00000374426.2
ENST00000395795.4 ENST00000395794.2 ENST00000374429.2 ENST00000395793.3 ENST00000343575.6 |
CXCL12
|
chemokine (C-X-C motif) ligand 12 |
chr19_-_11639931 | 10.48 |
ENST00000592312.1
ENST00000590480.1 ENST00000585318.1 ENST00000252440.7 ENST00000417981.2 ENST00000270517.7 |
ECSIT
|
ECSIT signalling integrator |
chr5_+_71014990 | 9.13 |
ENST00000296777.4
|
CARTPT
|
CART prepropeptide |
chr10_+_102790980 | 9.08 |
ENST00000393459.1
ENST00000224807.5 |
SFXN3
|
sideroflexin 3 |
chr12_+_52695617 | 8.56 |
ENST00000293525.5
|
KRT86
|
keratin 86 |
chr6_+_154360553 | 8.52 |
ENST00000452687.2
|
OPRM1
|
opioid receptor, mu 1 |
chr4_+_96012614 | 8.50 |
ENST00000264568.4
|
BMPR1B
|
bone morphogenetic protein receptor, type IB |
chr11_+_22359562 | 7.80 |
ENST00000263160.3
|
SLC17A6
|
solute carrier family 17 (vesicular glutamate transporter), member 6 |
chr7_+_150748288 | 7.62 |
ENST00000490540.1
|
ASIC3
|
acid-sensing (proton-gated) ion channel 3 |
chr7_-_100808843 | 6.61 |
ENST00000249330.2
|
VGF
|
VGF nerve growth factor inducible |
chr19_-_11639910 | 6.49 |
ENST00000588998.1
ENST00000586149.1 |
ECSIT
|
ECSIT signalling integrator |
chr1_+_171750776 | 5.83 |
ENST00000458517.1
ENST00000362019.3 ENST00000367737.5 ENST00000361735.3 |
METTL13
|
methyltransferase like 13 |
chr5_+_175298487 | 5.28 |
ENST00000393745.3
|
CPLX2
|
complexin 2 |
chr6_+_154360476 | 5.21 |
ENST00000428397.2
|
OPRM1
|
opioid receptor, mu 1 |
chr1_-_40105617 | 4.91 |
ENST00000372852.3
|
HEYL
|
hes-related family bHLH transcription factor with YRPW motif-like |
chr4_-_175750364 | 4.87 |
ENST00000340217.5
ENST00000274093.3 |
GLRA3
|
glycine receptor, alpha 3 |
chr11_-_6677018 | 4.78 |
ENST00000299441.3
|
DCHS1
|
dachsous cadherin-related 1 |
chr1_-_175712665 | 4.41 |
ENST00000263525.2
|
TNR
|
tenascin R |
chr3_+_120626919 | 4.36 |
ENST00000273666.6
ENST00000471454.1 ENST00000472879.1 ENST00000497029.1 ENST00000492541.1 |
STXBP5L
|
syntaxin binding protein 5-like |
chr10_-_79398127 | 4.32 |
ENST00000372443.1
|
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr20_-_60795296 | 4.27 |
ENST00000340177.5
|
HRH3
|
histamine receptor H3 |
chr11_-_125773085 | 4.17 |
ENST00000227474.3
ENST00000534158.1 ENST00000529801.1 |
PUS3
|
pseudouridylate synthase 3 |
chr12_+_71833756 | 3.67 |
ENST00000536515.1
ENST00000540815.2 |
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5 |
chr17_-_3337135 | 3.25 |
ENST00000248384.1
|
OR1E2
|
olfactory receptor, family 1, subfamily E, member 2 |
chr14_-_94759408 | 3.19 |
ENST00000554723.1
|
SERPINA10
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 |
chr20_+_36012051 | 3.18 |
ENST00000373567.2
|
SRC
|
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog |
chr14_-_94759361 | 2.93 |
ENST00000393096.1
|
SERPINA10
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 |
chr20_-_60795316 | 2.90 |
ENST00000317393.6
|
HRH3
|
histamine receptor H3 |
chr5_-_151304337 | 2.86 |
ENST00000455880.2
ENST00000545569.1 ENST00000274576.4 |
GLRA1
|
glycine receptor, alpha 1 |
chr7_-_100808394 | 1.85 |
ENST00000445482.2
|
VGF
|
VGF nerve growth factor inducible |
chr6_+_153071925 | 1.75 |
ENST00000367244.3
ENST00000367243.3 |
VIP
|
vasoactive intestinal peptide |
chr3_-_8686479 | 1.65 |
ENST00000544814.1
ENST00000427408.1 |
SSUH2
|
ssu-2 homolog (C. elegans) |
chr6_+_154360357 | 1.46 |
ENST00000330432.7
ENST00000360422.4 |
OPRM1
|
opioid receptor, mu 1 |
chr12_-_57443886 | 1.43 |
ENST00000300119.3
|
MYO1A
|
myosin IA |
chr2_+_226265364 | 0.84 |
ENST00000272907.6
|
NYAP2
|
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2 |
chr1_+_212606219 | 0.70 |
ENST00000366988.3
|
NENF
|
neudesin neurotrophic factor |
chr20_-_62284766 | 0.68 |
ENST00000370053.1
|
STMN3
|
stathmin-like 3 |
chr14_-_94759595 | 0.17 |
ENST00000261994.4
|
SERPINA10
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
24.3 | 72.9 | GO:1901899 | dense core granule biogenesis(GO:0061110) positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of dense core granule biogenesis(GO:2000705) |
19.7 | 78.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
17.6 | 140.7 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
16.7 | 50.2 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
13.6 | 27.1 | GO:0021586 | pons maturation(GO:0021586) |
12.4 | 61.9 | GO:1902075 | cellular response to salt(GO:1902075) |
9.5 | 37.9 | GO:0051866 | general adaptation syndrome(GO:0051866) |
8.7 | 52.2 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
8.2 | 131.8 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
7.6 | 68.5 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
7.4 | 66.8 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
7.3 | 29.3 | GO:0061358 | negative regulation of Wnt protein secretion(GO:0061358) |
6.4 | 25.5 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
5.6 | 231.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
5.2 | 228.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
5.1 | 51.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
5.1 | 35.9 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
4.8 | 58.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
4.6 | 9.1 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
4.3 | 17.3 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) synaptic transmission involved in micturition(GO:0060084) |
4.1 | 16.4 | GO:0019046 | release from viral latency(GO:0019046) |
3.7 | 11.2 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
3.6 | 21.6 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
3.6 | 71.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
3.4 | 13.6 | GO:0036269 | swimming behavior(GO:0036269) |
3.1 | 59.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
2.9 | 23.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
2.8 | 11.1 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
2.2 | 10.9 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
1.9 | 15.4 | GO:0043129 | surfactant homeostasis(GO:0043129) |
1.9 | 20.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
1.8 | 16.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
1.7 | 15.5 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
1.7 | 8.5 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
1.6 | 4.9 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
1.6 | 62.0 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
1.6 | 16.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
1.6 | 4.8 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.5 | 7.6 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
1.1 | 19.3 | GO:0031033 | myosin filament organization(GO:0031033) |
1.1 | 19.8 | GO:0030575 | nuclear body organization(GO:0030575) |
1.0 | 13.4 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
1.0 | 7.2 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) regulation of serotonin secretion(GO:0014062) negative regulation of serotonin secretion(GO:0014063) |
0.9 | 6.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.9 | 4.4 | GO:0048690 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
0.9 | 7.8 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.9 | 12.1 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.8 | 4.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) mRNA pseudouridine synthesis(GO:1990481) |
0.8 | 3.2 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.6 | 4.9 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.5 | 8.5 | GO:0002021 | response to dietary excess(GO:0002021) |
0.3 | 16.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.3 | 20.2 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.2 | 17.0 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 1.8 | GO:0070459 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) prolactin secretion(GO:0070459) |
0.2 | 1.8 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 45.3 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 4.4 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.1 | 61.8 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.1 | 0.7 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
0.1 | 9.1 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.1 | 0.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 8.6 | GO:0070268 | cornification(GO:0070268) |
0.1 | 1.4 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 5.8 | GO:0032259 | methylation(GO:0032259) |
0.0 | 1.7 | GO:0042476 | odontogenesis(GO:0042476) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
45.8 | 228.9 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
12.5 | 50.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
12.0 | 131.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
12.0 | 35.9 | GO:0002139 | stereocilia coupling link(GO:0002139) |
10.5 | 126.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
8.9 | 62.0 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
7.8 | 46.7 | GO:1990769 | proximal neuron projection(GO:1990769) |
6.3 | 37.9 | GO:0032280 | symmetric synapse(GO:0032280) |
5.6 | 61.9 | GO:0044327 | dendritic spine head(GO:0044327) |
4.3 | 72.9 | GO:0042583 | chromaffin granule(GO:0042583) |
3.8 | 300.6 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
3.0 | 27.1 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
2.9 | 23.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
2.1 | 68.5 | GO:0000795 | synaptonemal complex(GO:0000795) |
1.6 | 4.9 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
1.5 | 140.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.5 | 4.4 | GO:0072534 | perineuronal net(GO:0072534) |
1.5 | 78.7 | GO:0043198 | dendritic shaft(GO:0043198) |
1.4 | 20.2 | GO:0044295 | axonal growth cone(GO:0044295) |
1.3 | 16.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
1.2 | 11.2 | GO:0005579 | membrane attack complex(GO:0005579) |
1.1 | 29.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.8 | 45.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.7 | 17.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.7 | 8.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.4 | 13.5 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.3 | 66.3 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.3 | 92.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 8.6 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 15.5 | GO:0043197 | dendritic spine(GO:0043197) |
0.2 | 16.2 | GO:0005901 | caveola(GO:0005901) |
0.1 | 20.7 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 11.1 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 37.8 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 15.4 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 17.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 1.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 101.2 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 31.9 | GO:0005886 | plasma membrane(GO:0005886) |
0.0 | 9.1 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 0.7 | GO:0030426 | growth cone(GO:0030426) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
19.1 | 228.9 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
16.8 | 185.0 | GO:0008430 | selenium binding(GO:0008430) |
16.7 | 50.2 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
12.4 | 62.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
8.8 | 140.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
8.3 | 58.0 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
7.5 | 52.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
7.3 | 29.3 | GO:0004979 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
7.2 | 78.7 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
6.5 | 45.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
5.4 | 27.1 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
5.4 | 37.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
2.7 | 71.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
2.6 | 15.5 | GO:0005499 | vitamin D binding(GO:0005499) |
2.5 | 19.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
2.3 | 16.2 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
2.1 | 20.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
1.9 | 13.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
1.9 | 23.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.5 | 7.7 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.5 | 7.6 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
1.4 | 16.4 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.4 | 16.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.3 | 13.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
1.3 | 19.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.2 | 4.9 | GO:0035939 | microsatellite binding(GO:0035939) |
1.0 | 12.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
1.0 | 54.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.9 | 8.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.9 | 46.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.9 | 11.1 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.8 | 7.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.7 | 17.3 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.7 | 10.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.7 | 81.1 | GO:0005179 | hormone activity(GO:0005179) |
0.5 | 66.8 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.5 | 4.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.4 | 7.8 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.4 | 15.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 11.2 | GO:0008009 | chemokine activity(GO:0008009) |
0.3 | 16.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.2 | 231.9 | GO:0005215 | transporter activity(GO:0005215) |
0.1 | 17.0 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 21.6 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.1 | 61.9 | GO:0019900 | kinase binding(GO:0019900) |
0.1 | 35.9 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.1 | 5.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 5.8 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 4.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 4.5 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 1.4 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 8.6 | GO:0005198 | structural molecule activity(GO:0005198) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 228.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.7 | 73.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 37.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.3 | 15.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 20.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 29.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 3.2 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 10.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 16.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 8.5 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 9.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 6.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 4.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.7 | 256.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
3.8 | 68.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
2.6 | 52.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.9 | 66.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.8 | 50.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.4 | 19.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
1.4 | 45.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
1.0 | 17.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.9 | 11.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.8 | 20.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.8 | 29.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.7 | 86.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.5 | 21.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.5 | 46.7 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.5 | 91.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.4 | 15.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 3.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.4 | 16.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.3 | 8.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 17.0 | REACTOME TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7 8 OR 9 ACTIVATION | Genes involved in TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation |
0.1 | 1.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 4.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |